143 related articles for article (PubMed ID: 22546644)
1. Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients.
Argani H; Ghorbanihaghjo A; Panahi G; Rashtchizadeh N; Safa J; Meimand SM
Clin Biochem; 2012 Jul; 45(10-11):775-9. PubMed ID: 22546644
[TBL] [Abstract][Full Text] [Related]
2. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
Hashemi J; Joshaghani HR; Akaberi A; Hesari Z; Ghanbari R; Mohammadzadeh M; Golshan AR
Arch Iran Med; 2017 Dec; 20(12):752-755. PubMed ID: 29664315
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
4. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
5. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
[TBL] [Abstract][Full Text] [Related]
6. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
Taskapan MC; Taskapan H; Comert M; Temel I; Yagmur J; Ulutas O
Ren Fail; 2013; 35(4):477-82. PubMed ID: 23438291
[TBL] [Abstract][Full Text] [Related]
7. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein.
Zhou Y; Ni Z; Zhang J; Zhang W; Wu Q; Shen G; Wang Y; Qian J
Vasc Med; 2013 Apr; 18(2):85-91. PubMed ID: 23609129
[TBL] [Abstract][Full Text] [Related]
8. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
9. Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up.
Zhou Y; Zhang J; Zhu M; Lu R; Wang Y; Ni Z
Blood Purif; 2015; 39(4):266-73. PubMed ID: 25924996
[TBL] [Abstract][Full Text] [Related]
10. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
[TBL] [Abstract][Full Text] [Related]
11. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
12. Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.
Liang J; Wang Z; Liu G; Zhan J; Jiang L; Jiang Z
Ren Fail; 2014 Feb; 36(1):65-8. PubMed ID: 24028708
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
[TBL] [Abstract][Full Text] [Related]
14. Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.
Okamoto T; Tsutaya C; Hatakeyama S; Konishi S; Okita K; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
Int Urol Nephrol; 2018 Sep; 50(9):1713-1720. PubMed ID: 30128921
[TBL] [Abstract][Full Text] [Related]
15. The importance of fetuin-A in vascular calcification in children with chronic kidney disease.
Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D
Adv Clin Exp Med; 2019 Apr; 28(4):499-505. PubMed ID: 30070080
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
[TBL] [Abstract][Full Text] [Related]
17. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
[TBL] [Abstract][Full Text] [Related]
18. Changes in circulating biomarkers during a single hemodialysis session.
Yamamoto T; Nascimento MM; Hayashi SY; Qureshi AR; Waniewski J; Brodin LÅ; Anderstam B; Lind B; Riella MC; Seeberger A; Lindholm B
Hemodial Int; 2013 Jan; 17(1):59-66. PubMed ID: 22716238
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease.
Boehme M; Kaehne F; Kuehne A; Bernhardt W; Schröder M; Pommer W; Fischer C; Becker H; Müller C; Schindler R
Nephrol Dial Transplant; 2007 Aug; 22(8):2224-9. PubMed ID: 17496115
[TBL] [Abstract][Full Text] [Related]
20. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
